BioLife Solutions receives ISO 13485:2003 certification BioLife Solutions, Inc. , a respected developer, manufacturer, and marketing expert of biopreservation equipment for cells, cells, and organs, today announced that it has effectively finished audits of its quality systems and GMP creation service in Bothell, Washington by BSI Group and offers been issued a qualification to ISO 13485:2003, a global regular for quality systems helping the look, development, and produce of medical products male pattern baldness . Mike Rice, BioLife’s chairman and CEO, observed, This achievement is usually a strategic quality milestone for BioLife. Our developing clinical customer bottom expects us to create a higher bar for the creation of our GMP biopreservation mass media products, because so many customer applications are the use of our items as a mixed preservative/injection delivery remedy for cell-based therapies utilized to take care of cancer, heart failing, and a bunch of other illnesses.
Related StoriesCaltech experts find antibody that may detect, neutralize HIV infections in contaminated patientsBrodalumab therapy achieves 100 percent decrease in psoriasis symptomsCalcitonin-gene related peptide antibody inhibition displays migraine prevention promise BioInvent has utilized F.We.R.S.T.I.R.S.T. With vast amounts of binders obtainable in the libraries and state-of-the-artwork in vitro and in vivo cancers and immunological assays, we are able to discover antibodies with the most effective properties for onward advancement.. BioInvent International receives US patent for medication discovery technology F.We.R.S.T.